Sarver Vrooman Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Sarver Vrooman Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.3K	Sell	441 -61	-12%	-$5.35K	0.02%	91
2026 Q1	$45.4K	Buy	502 +127	+34%	+$11.7K	0.03%	66
2025 Q4	$33.7K	Sell	375 -227	-38%	-$21.5K	0.02%	90
2025 Q3	$59.3K	Hold	602	–	–	0.04%	72
2025 Q2	$54.9K	Sell	602 -136	-18%	-$13.2K	0.04%	78
2025 Q1	$83.5K	Buy	+738	New	+$79K	0.06%	27

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Sarver Vrooman Wealth Advisors's ZBH Position: Q2 2026 in Review

Sarver Vrooman Wealth Advisors reduced its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, selling an estimated $5.35K and leaving 441 shares worth $37.3K. The position accounts for 0.02% of the portfolio, ranked #91.

Sarver Vrooman Wealth Advisors first reported a position in ZBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $83.5K in Q1 2025. 166 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Sarver Vrooman Wealth Advisors held 441 shares of Zimmer Biomet worth $37.3K as of Q2 2026.
Sarver Vrooman Wealth Advisors sold 61 Zimmer Biomet shares in Q2 2026, an estimated $5.35K.
Zimmer Biomet made up 0.02% of Sarver Vrooman Wealth Advisors's portfolio in Q2 2026, its #91 holding.
Sarver Vrooman Wealth Advisors first reported a position in Zimmer Biomet in Q1 2025 and has held it in 6 quarters since.
Sarver Vrooman Wealth Advisors's Zimmer Biomet position peaked at $83.5K in Q1 2025.
166 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.